GROUP NEWS

Closed LinkedIn Group - interested in joining?

HOW TO

Case 1: you are already registered at LinkedIn

Just follow this link to the group page https://www.linkedin.com/groups/8984808/ and tick the blue “Request to join” button. Once the chairs have accepted your request, you are part of the group.

 

Case 2: you are NOT registered at LinkedIn

Create an account/profile at www.linkedin.com

Then follow this link to the group page https://www.linkedin.com/groups/8984808/ and tick the “Request to join” button. Once the chairs have accepted your request, you are part of the group.

New Co-Chair

Marleen Keyaerts elected as new Co-Chair. Welcome, Marleen, to the Group Leadership team!

ESMI Study Group on “Oncoimmunology & Therapy" | OncIMMO

Importance & Purpose

The Oncoimmunology and Therapy study group strongly believes that in vivo imaging is an essential part of the translation of new concepts and immunotherapies to the benefit of patients, by facilitating:

  • studies to further improve our mechanistic understanding of the immune system
  • studies to better understand the mechanisms of action of existing and new immunotherapies in preclinical and clinical settings
  • hypothesis-driven design of new immunotherapeutics and combination therapies.

We therefore will act to:

  • reach out and advertise use of imaging in different immunotherapy areas
  • further spread implementation of imaging into oncoimmunology and immunotherapy research through information and education
  • stimulate new scientific collaborations with related interest groups and scientific communities (CIMT, ESMO, ISCT etc.) that foster all of the above mentioned aims.